CEP55 and ovarian carcinoma: Importantly, overexpression of CEP55 promoted cell cycle transition in human gastric cancer15; whereas knockdown of CEP55 inhibited cell growth in breast cancer20 and gastric cancer15, decreased cellular motility and invasion in ovarian cancer cells21, and induced cell apoptosis in glioma22.